---
title: "Telomir Pharmaceuticals (TELO.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TELO.US/norm.md"
symbol: "TELO.US"
name: "Telomir Pharmaceuticals"
parent: "https://longbridge.com/en/quote/TELO.US.md"
datetime: "2026-05-21T23:16:51.408Z"
locales:
  - [en](https://longbridge.com/en/quote/TELO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TELO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TELO.US/norm.md)
---

# Telomir Pharmaceuticals (TELO.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0300 | -0.0615 | -0.0340 | -0.1689 | -0.0732 |
| ROE | -72.89% | -127.90% | -118.20% | -12670.13% | -3618.50% |
| Revenue | - | - | - | - | - |
| Net income | -990947.00 | -2.06M | -1.10M | -5.07M | -2.18M |
| Operating income | -1.04M | -2.13M | -1.15M | -5.07M | -2.19M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 5.79M | 7.34M | 7.40M | 829611.00 | 491188.00 |
| Leverage | 1.17 | 1.24 | 1.06 | 1.72 | -3.05 |
| BVPS | 0.1443 | 0.1720 | 0.2063 | 0.0158 | -0.0054 |
| Turnover | - | - | - | - | - |
| Cash & STI | 5.56M | 7.29M | 7.33M | 754323.00 | 402999.00 |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -5.36M | -6.81M | -7.24M | -660891.00 | -309567.00 |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.77M | -1.20M | -927264.00 | -696445.00 | -863132.00 |
| Investing CF | - | - | - | - | - |
| Financing CF | 47351.00 | 1.16M | 7.50M | 1.05M | - |
| Free CF | -1.15M | -699133.00 | -639660.00 | -3.46M | -50667.00 |
| OCF coverage | -999.51% | - | - | - | - |
| Repaid & issued | 224789.00 | 155518.00 | - | - | - |
| CapEx | - | - | - | - | - |